Skip to content
Home/Companies/Healthcare/Medpace

Medpace

Healthcare·US·Exited 2017·Held 3yr
Entry
2014
Hold
3yr
Exit
2017

Who owns Medpace?

Medpace was owned by Cinven through Cinven Fifth Fund (2012 vintage) from 2014 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Cinven
Investor
Cinven
Cinven Fifth Fund · 2012 · Buyout

Key facts

HQUS
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Cinven Fifth Fund

Other portfolio companies in the same fund.

Labco
Active
MedTechFrance· 2015
Premium Credit
Exited 2022
FintechUK· 2015
to
SYNLAB
Synlab
Active
MedTechUK· 2015
Tractel
Tractel
Exited 2022
IndustrialsFrance· 2015
to
Northgate Public Services
Exited 2018
TMTUK· 2014
to
Prezioso Linjebygg
Exited 2016
ConstructionNorway· 2014
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Medpace

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Medpace?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Medpace.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue